Duffy-null基因型与黑人女性上皮性卵巢癌生存的队列研究
本研究纳入408例黑人上皮性卵巢癌(EOC)患者(含275例高级别浆液性癌),采用贝叶斯模型分析ACKR1基因Duffy-null(CC)基因型与入组后全因死亡的关系。调整分期、年龄、社会经济因素和家族史后,CC基因型与EOC全因死亡风险降低相关(调整HR=0.60,95%CI 0.36-0.99)。在HGSC中,CC基因型与更高的非洲祖源、更低的ACKR1表达(p=0.049)、更低的细胞毒性T细胞丰度(p=0.062)及更高频率的同源重组缺陷(HRD)肿瘤(p=0.051)相关。
要点
- Duffy-null(CC)基因型与黑人女性EOC全因死亡风险降低40%相关。
- 在HGSC中,CC基因型与更低ACKR1表达、更低细胞毒性T细胞丰度及更高HRD频率相关。
- 该发现为假设生成性,需进一步复制和机制研究。
核心结论
- 在黑人女性EOC患者中,Duffy-null(CC)基因型与全因死亡风险降低相关(调整HR=0.60,95%CI 0.36-0.99)。
- 该关联在HGSC亚组中伴随免疫和基因组特征差异,但需进一步验证。
研究设计与样本
- 研究纳入408例黑人EOC患者,其中275例为HGSC。
- 采用贝叶斯建模估计风险比(HR)和95%可信区间(CI),调整分期、诊断年龄、社会经济因素和卵巢癌家族史。
- 对部分HGSC病例进行测序检测肿瘤免疫和遗传特征。
主要发现
- CC基因型与EOC全因死亡风险降低相关(调整HR=0.60,95%CI 0.36-0.99)。
- 在HGSC中,CC基因型与更高的非洲祖源、更低的ACKR1表达(p=0.049)、更低的细胞毒性T细胞丰度(p=0.062)和更高频率的HRD肿瘤(p=0.051)相关。
临床怎么用
- Duffy-null基因型可能作为黑人女性EOC预后评估的候选生物标志物,但尚未推荐常规检测。
- 临床决策仍需结合分期、组织学类型等现有预后因素。
局限性
- 研究为观察性队列,无法确立因果关系。
- 作者指出为假设生成性发现,需外部复制和机制研究。
- 肿瘤免疫和遗传特征仅来自部分HGSC病例的测序。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Black women experience poor survival from epithelial ovarian cancer (EOC) for all stages at diagnosis and histotypes. The contribution of an ancestry-related genotype in the Atypical Chemokine Receptor 1 (ACKR1) gene to mortality after an EOC diagnosis in Black women has not been previously reported. METHODS: The relationship between the Duffy-null genotype (CC) in the ACKR1 gene and overall post-enrollment mortality in 408 Black women with EOC, including 275 with high-grade serous ovarian cancer (HGSC) was evaluated using Bayesian modeling approach to estimate hazard ratios (HR) and 95% credible intervals (CI) adjusting for stage, age at diagnosis, socioeconomic factors, and ovarian cancer family history. Tumor immune and genetic features were generated from sequencing assays on subsets of the HGSC cases. RESULTS: The CC genotype was associated with reduced all-cause mortality among EOC cases (adjusted HR = 0.60, 95% CI: 0.36-0.99). Among HGSC, the CC genotype was associated with higher African origin, lower ACKR1 expression (p = 0.049), lower cytotoxic T cell abundance (p = 0.062), and a higher frequency of homologous recombination deficient (HRD) tumors (p = 0.051). CONCLUSIONS: In this study, the Duffy-null CC genotype was associated with 40% lower EOC all-cause mortality in Black women. These are hypothesis-generating findings that require replication and further inquiry into mechanisms.
引用
- Schildkraut JM, Marks JR, Peres LC, et al. The Duffy-Null genotype and epithelial ovarian cancer survival in a cohort of Black women. Gynecol Oncol. 2026. PMID: 42950522. doi:10.1016/j.ygyno.2026.10.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。